Good news!
"50 pounds. The average weight loss for people taking Eli Lilly’s Zepbound obesity drug, compared with an average loss of 33 pounds for those taking Novo Nordisk’s Wegovy, in a Lilly-sponsored study. It was the first randomized clinical trial comparing Zepbound and Wegovy against each other."
No comments:
Post a Comment